Rivaroxaban, a direct factor Xa inhibitor, ameliorates angiotensin II-induced renal damage through inhibition of protease-activated receptor pathway-mediated inflammatory response
28 August 2017 (14:00 - 18:00)
Organised by:
Abstract
About the speaker
Hirosaki University Graduate School of Medicine, Hirosaki (Japan)
33 More presentations in this session
Access the full session
The Event
ESC Congress 2017
28 August 2017
14:00 CET
